Yahoo · Oct 21, 2026
Embla Medical (CPSE:EMBLA) Stock Faces Q3 Results And Softer Growth Outlook
Embla Medical hf walked into its Q3 2026 release with the share price down over the past week, month and quarter, even as the stock traded on a trailing P/E of 17.7x, well below European medical equipment peers. The fresh numbers show Q3 revenue of US$249.6m and net profit of US$26.1m, with an EBITDA margin of 22% holding steady against last year. That mix, solid profitability but trimmed full year organic growth guidance to about 5%, sets up a sentiment clash between a cautious tape and a...

